Skip to main content
ConductScienceScienceDex

Xiaoguang Margaret Liu

NIH Rank #5969
Unclaimed recordClaim profile
  • R01 Holder
  • Translational
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11598177Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • ENGINEERING (ALL TYPES)
  • Genetics

NIH Funding · FY2024

Linked Award Amount
$1.9M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#5,969
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Xiaoguang Margaret Liu. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Xiaoguang Margaret Liu as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA281980-02R01
    Dual-payload antibody-drug conjugate for chemo-immunotherapy of triple-negative breast cancers
    Ohio State University
    $553.1K
    award amount
  • 5R01CA262028-03R01
    Combine mitochondrial gene therapy and synthetic lethal chemotherapy to treat triple-negative breast cancer
    Ohio State University
    $544.4K
    award amount
  • 5R01CA238273-05R01
    Synergistic Targeted Therapy of Antibody-Drug Conjugates for Triple-Negative Breast Cancer
    University of Alabama at Birmingham
    $462.9K
    award amount
  • 5R01CA242917-05R01
    Identifying a New Biological Target for Breast Cancer Therapy That Contributes to Disparities for African-American Women
    University of Alabama at Birmingham
    $322.7K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Xiaoguang Margaret Liu as a PI.

Ohio State University
OH
$1.1M
2 grants
University of Alabama at Birmingham
AL
$785.6K
2 grants

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Ohio State University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5969
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  7. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Xiaoguang Margaret Liu.

Eddy Shih Hsin Yang
Ohio State University
3
shared awards
Lufang Zhou
Ohio State University
3
shared awards
Runhua Runa Liu
University of Alabama at Birmingham
3
shared awards
William E. Carson
Ohio State University
3
shared awards
Lizhong Wang
University of Alabama at Birmingham
1
shared award

Explore further

Find collaborators for Xiaoguang Margaret Liu

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →